Search results
Aimin Xu is currently a Chair Professor jointly appointed by the Department of Medicine and the Department of Pharmacology & Pharmacy, and also the director for State Key Laboratory of Pharmaceutical Biotechnology (www.sklpb.hku.hk) at the University of Hong Kong.
Aimin Xu. Department of Medicine, Department of Pharmacology and Pharmacy, the University of Hong Kong. Verified email at hku.hk. Obesity diabetes biomarker discovery adipocyte biology adipokines. Articles Cited by Public access. Title. ... AWK Tso, A Xu, PC Sham, NMS Wat, Y Wang, CHY Fong, BMY Cheung, ... Diabetes care 30 (10), 2667-2672, 2007 ...
Professor Aimin Xu and his research associates Research Interests Obesity is a major risk factor of type 2 diabetes (T2DM), insulin resistance and cardiovascular diseases (CVDs).
Our primary research interest is to investigate the role of adipokines in the pathogenesis of obesity-related insulin resistance, systemic inflammation, T2DM and vascular dysfunctions in animal models and human subjects.
ORCID record for aimin xu. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.
Aimin XU | Cited by 36,452 | of The University of Hong Kong, Hong Kong (HKU) | Read 711 publications | Contact Aimin XU
Aimin XU | Cited by 33,716 | of The University of Hong Kong, Hong Kong (HKU) | Read 680 publications | Contact Aimin XU
